Cognition Therapeutics, Inc.

NASDAQ:CGTX

0.4744 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 28.53334.67129.92232.96937.1938.8141.56246.6145.77151.50954.7218.3111.313.3735.189-2.89
Short Term Investments 0000000000000005.78
Cash and Short Term Investments 28.53334.67129.92232.96937.1938.8141.56246.6145.77151.50954.7218.3111.313.3735.1892.89
Net Receivables 3.0990.8611.2811.6382.3931.6093.6722.5283.2952.7942.2661.1472.5522.3171.1520
Inventory 00000000-3.2950-1.7990.5710.7660.2350.5440
Other Current Assets 1.9182.4363.0191.4331.9682.3822.4131.7944.9722.1370.0110.010.0650.0270.0230
Total Current Assets 33.5537.96834.22236.0441.55142.80147.64750.93250.74356.4458.99210.03814.68315.9526.9082.89
Non-Current Assets:
Property, Plant & Equipment, Net 0.8190.8830.9410.9770.9841.0271.0460.9370.7840.8390.1450.1410.1650.1880.2110
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 0000000000000000
Tax Assets 0000000000000000
Other Non-Current Assets 0-0-01.7551.4251.8351.7321.6881.2851.41703.212.4410.3720-2.89
Total Non-Current Assets 0.8190.8830.9412.7322.4092.8622.7782.6252.0692.2560.1453.3512.6060.560.211-2.89
Total Assets 34.36938.85135.16338.77243.9645.66350.42553.55752.81258.69659.13713.38917.28916.5127.1190
Liabilities & Equity:
Current Liabilities:
Account Payables 3.0342.6393.6952.8594.063.123.2168.0873.3043.9974.1682.7753.6573.1872.0030
Short Term Debt 0.1840.180.1740.1720.3830.5840.7830.1140.5630.949-0.75300000
Tax Payables 0000000000.125000000
Deferred Revenue 1.4531.5841.7010.911.0561.6461.7021.6011.2841.3160.75300000
Other Current Liabilities 6.2495.14.5994.2882.4152.1152.0942.3141.6671.3832.9431.6532.5671.1511.2470
Total Current Liabilities 10.929.50310.1698.2297.9147.4657.79512.1166.8187.6457.8644.4286.2244.3383.250
Non-Current Liabilities:
Long Term Debt 0.440.4880.520.5650.6080.6510.6950.6030.4040.446084.76184.76112.69112.8520
Deferred Revenue Non-Current 0001.0521.0521.7641.6861.5181.6911.865000000
Deferred Tax Liabilities Non-Current 000-1.052-1.052-1.764-0.695-1.518-1.691-1.865000000
Other Non-Current Liabilities -0-0-01.0521.0521.7640.6951.5181.69104.16810.9189.98667.33759.2010
Total Non-Current Liabilities 0.440.4880.521.6171.662.4152.3812.1212.0952.3114.16895.67994.74780.02872.0530
Total Liabilities 11.369.99110.6899.8469.5749.8810.17614.2378.9139.9567.864100.107100.97184.36675.3030
Equity:
Preferred Stock 000000000004.61684.76155.3755.3752.927
Common Stock 0.040.040.0320.030.030.0290.0290.0240.0220.0220.0220.0010.0010.0020.0010
Retained Earnings -157.381-150.34-141.189-133.048-126.299-121.573-115.401-110.219-103.594-97.842-94.004-86.665-83.555-67.997-68.220
Accumulated Other Comprehensive Income/Loss 00-0.195-0.196-0.196-0.195-0.199-0.201-0.2-0.197-0.198-0.196-0.193-0.192-0.187-58.422
Other Total Stockholders Equity 180.35179.16165.826162.14160.851157.522155.82149.716147.671146.757145.453-4.474-84.696-55.037-55.1480
Total Shareholders Equity 23.00928.8624.47428.92634.38635.78340.24939.3243.89948.7451.273-86.718-83.682-67.854-68.184-5.495
Total Equity 23.00928.8624.47428.92634.38635.78340.24939.3243.89948.7451.273-86.718-83.682-67.854-68.184-5.495
Total Liabilities & Shareholders Equity 34.36938.85135.16338.77243.9645.66350.42553.55752.81258.69659.13713.38917.28916.5127.119-5.495